Cibc Private Wealth Group, LLC Viking Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,351 shares of VKTX stock, worth $39,111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,351
Previous 500
170.2%
Holding current value
$39,111
Previous $31,000
74.19%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$294 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$174 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$143 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$75.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$62.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.22B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...